Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice

Blood

Volumn 90, Issue 3, 1997, Pages 944-951

  Huang, Zhong Fu ^a   Higuchi, Darryl ^a   Lasky, Nina ^a   Broze Jr , George J ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; EMBRYO; FETUS DEATH; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030738021     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.944     Document Type: Article

References (28)

1. Broze GJ Jr: Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 46:103, 1995
2. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr: Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 264:18831, 1989
3. Novotny WF, Girard TJ, Miletich JP. Broze GJ Jr: Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor. Blood 72:2020, 1988
4. Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50:803, 1988
5. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ Jr: Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood 78:387, 1991
6. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr: Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 263:6001, 1988
7. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338:518, 1989
8. Wesselschmidt RI, Likert KM, Huang Z-F, MacPhail L, Broze GJ Jr: Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrinolysis 4:661, 1993
9. Enjyoji K, Miyata T, Kamikubo Y, Kato H: Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor. A segment, Gly212-Phe243, of the third Kunitz domain is a heparin binding site. Biochemistry 34:5725, 1995
10. Ho G, Toomey JR, Broze GJ Jr, Schwartz A: Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem 271:9497, 1996
11. Sevinsky JR, Rao SVM, Ruf W: Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 133:293, 1996
12. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI: Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 88:708, 1991
13. Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI: Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Schwartzman reaction. Blood 78:1496, 1991
14. Warn-Cramer BJ, Rapaport SI: Studies of factor Xa/phospholipid induced intravascular coagulation in rabbits. Effects of immunodepletion of tissue factor pathway inhibitor. Arterioscler Thromb 13:1551, 1993
15. Day KC, Hoffman LC, Palmier MO, Kretzmer KK, Huang MD, Pyla EY, Spokas E, Broze GJ Jr, Warren TG, Wun TC: Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood 76:1538, 1990
16. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from E. coli septic shock. J Clin Invest 91:2850, 1993
17. Girard TJ, MacPhail LA, Likert KM, Novotny WF, Miletich JP, Broze GJ Jr: Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science 248:1421, 1990
18. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L: Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 5:551, 1994
19. - trinsic pathway of coagulation. Biochemistry 30:1571, 1991
20. Lijnen HR, Carmeliet P, Bouche A, Moons L, Ploplis VA, Plow EF, Collen D: Restoration of thrombolytic potential in plasminogen-deficient mice by bolus injection. Blood 88:870, 1996
21. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D: Role of tissue factor in embryonic blood vessel development. Nature 383:73, 1996
22. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EN, Degen JL: Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 93:6258, 1996
23. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr: Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583, 1996
24. Cui J, O'Shea KS, Purkayastha A, Saunders TL, Ginsburg D: Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384:66, 1996
25. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter S, Degen J: Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9:2020, 1995
26. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR: Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516, 1996
27. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119, 1995
28. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995